ICS Maugeri
Pavia, 27100, Italy
NCT Number: NCT05758649
The study will assess cardiac and psychological profile at 2-3 months after recovery from COVID-19 infection.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Pavia, 27100, Italy
A significant proportion of patients hospitalized for COVID-19 showed laboratory signs of myocardial damage, detected by elevated troponin levels, and these were associated with more severe clinical course and higher mortality. Moreover, it is unknown how the health emergency and the associated conditions may have influenced and still influence the psychological experience of the affected people.
Thus, in order to promote continuity of care, post-COVID-19 disease clinics have therefore been activated dedicated to a specific follow-up program for monitoring long-term alterations and for the early identification of patients requiring rehabilitation.
The program includes a first follow-up visit (2-3 months after recovery) including cardiac (2D-echocardiography, six-minute walking test, autonomic function evaluation) and psychological (Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD) National Stressful Events Survey PTSD Short Scale (NSESSS)) evaluation.
A second follow-up visit will be performed at 12 months in the form of structured interview,
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months
Istituti Clinici Scientifici Maugeri SpA
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06784713
COVID - 19, COVID-19
Tartu, Estonia
View Trial DetailsNCT07709234
Behavior, Behavioral Symptoms
View Trial DetailsNCT07359482
COVID-19, Chronic Disease
Amsterdam-Zuidoost, Netherlands
View Trial DetailsNCT05880108
Behavior, Body Weight
Baltimore, Maryland, United States
View Trial Details